Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Depth of neutrophil mobilization stratifies survival in ST-elevation myocardial infarction.

Nature cardiovascular research·2026
Same author

Implementation of the kidney protection strategy in critically ill patients with acute kidney injury - a multi-center prospective cohort study.

Critical care (London, England)·2026
Same author

Proteomic signatures of renal recovery from acute kidney injury-a translational study in critically ill postoperative patients.

Intensive care medicine experimental·2026
Same author

Phosphorylated toll-like receptor 4 defines a high-risk sepsis endotype.

Critical care (London, England)·2026
Same author

Association between organ dysfunction during ICU stay and post-intensive care syndrome at 1 year after ICU discharge: a prospective cohort study.

Journal of intensive care·2026
Same author

Withholding or continuing glucose-lowering drugs for elective surgery in patients with type 2 diabetes mellitus: a secondary analysis of the MOPED international, prospective, observational study.

British journal of anaesthesia·2026
Same journal

Research advances and application prospects of CAR-T therapy in the treatment of age-related diseases.

Frontiers in immunology·2026
Same journal

Machine learning-driven identification and immunohistochemical validation of an integrated immune-inflammatory phenotype for disease-free survival stratification in breast cancer.

Frontiers in immunology·2026
Same journal

Modified treatment protocol for pediatric systemic lupus erythematosus-associated hemophagocytic lymphohistiocytosis with central nervous system involvement: a case report.

Frontiers in immunology·2026
Same journal

Exploratory characterization of IgG1/IgG4 glycosylation and monocyte-derived dendritic cell responses in esophageal squamous cell carcinoma.

Frontiers in immunology·2026
Same journal

JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases.

Frontiers in immunology·2026
Same journal

Cross-talk among novel programmed cell death pathways: a decisive network in renal ischemia-reperfusion injury.

Frontiers in immunology·2026
See all related articles

Related Experiment Video

Updated: May 19, 2026

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

CXCR2: From Bench to Bedside.

Anika Stadtmann1, Alexander Zarbock

  • 1Department of Anaesthesiology, Intensive Care and Pain Medicine, University of Münster Münster, Germany.

Frontiers in Immunology
|September 1, 2012
PubMed
Summary
This summary is machine-generated.

This review explores CXC chemokine receptor 2 (CXCR2) and its role in immune responses. CXCR2 inhibitors show promise for treating diseases like acute lung injury and sepsis.

Keywords:
CXCR2Gαi-signalingchemokine receptor

More Related Videos

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
06:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
10:10

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries

Published on: March 31, 2019

Related Experiment Videos

Last Updated: May 19, 2026

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
06:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
10:10

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries

Published on: March 31, 2019

Area of Science:

  • Immunology
  • Molecular Biology
  • Pharmacology

Background:

  • Leukocyte recruitment is vital for innate immunity, driven by chemokine signaling.
  • CXC chemokine receptor 2 (CXCR2) on neutrophils is key in this process.
  • CXCR2's role in various diseases is under extensive investigation.

Purpose of the Study:

  • To review CXCR2 structure and signaling pathways.
  • To detail CXCR2's involvement in acute lung injury, COPD, sepsis, and ischemia-reperfusion injury.
  • To summarize clinical trial outcomes for CXCR2 inhibitors.

Main Methods:

  • Literature review of CXCR2 structure and function.
  • Analysis of studies on CXCR2 in disease models.
  • Summary of clinical trial data for CXCR2 inhibitors.

Main Results:

  • CXCR2 activation leads to integrin activation and leukocyte recruitment.
  • CXCR2 plays a significant role in inflammatory diseases.
  • Clinical trials of CXCR2 inhibitors have yielded promising results.

Conclusions:

  • CXCR2 is a critical target for modulating immune responses.
  • CXCR2 inhibitors represent a potential therapeutic strategy for inflammatory conditions.